167 related articles for article (PubMed ID: 25767386)
1. Antileukemic effect of zerumbone-loaded nanostructured lipid carrier in WEHI-3B cell-induced murine leukemia model.
Rahman HS; Rasedee A; How CW; Zeenathul NA; Chartrand MS; Yeap SK; Abdul AB; Tan SW; Othman HH; Ajdari Z; Namvar F; Arulselvan P; Fakurazi S; Mehrbod P; Daneshvar N; Begum H
Int J Nanomedicine; 2015; 10():1649-66. PubMed ID: 25767386
[TBL] [Abstract][Full Text] [Related]
2. Zerumbone-loaded nanostructured lipid carrier induces G2/M cell cycle arrest and apoptosis via mitochondrial pathway in a human lymphoblastic leukemia cell line.
Rahman HS; Rasedee A; Abdul AB; Zeenathul NA; Othman HH; Yeap SK; How CW; Hafiza WA
Int J Nanomedicine; 2014; 9():527-38. PubMed ID: 24549090
[TBL] [Abstract][Full Text] [Related]
3. Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect.
Rahman HS; Rasedee A; How CW; Abdul AB; Zeenathul NA; Othman HH; Saeed MI; Yeap SK
Int J Nanomedicine; 2013; 8():2769-81. PubMed ID: 23946649
[TBL] [Abstract][Full Text] [Related]
4. Zerumbone-Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma Cells.
Foong JN; Selvarajah GT; Rasedee A; Rahman HS; How CW; Beh CY; Teo GY; Ku CL
Biomed Res Int; 2018; 2018():8691569. PubMed ID: 30410940
[TBL] [Abstract][Full Text] [Related]
5. Acute toxicity study of zerumbone-loaded nanostructured lipid carrier on BALB/c mice model.
Rahman HS; Rasedee A; Othman HH; Chartrand MS; Namvar F; Yeap SK; Abdul Samad N; Andas RJ; Muhammad Nadzri N; Anasamy T; Ng KB; How CW
Biomed Res Int; 2014; 2014():563930. PubMed ID: 25276798
[TBL] [Abstract][Full Text] [Related]
6. Zerumbone, a bioactive sesquiterpene, induces G2/M cell cycle arrest and apoptosis in leukemia cells via a Fas- and mitochondria-mediated pathway.
Xian M; Ito K; Nakazato T; Shimizu T; Chen CK; Yamato K; Murakami A; Ohigashi H; Ikeda Y; Kizaki M
Cancer Sci; 2007 Jan; 98(1):118-26. PubMed ID: 17129359
[TBL] [Abstract][Full Text] [Related]
7. In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells.
Nordin N; Yeap SK; Rahman HS; Zamberi NR; Abu N; Mohamad NE; How CW; Masarudin MJ; Abdullah R; Alitheen NB
Sci Rep; 2019 Feb; 9(1):1614. PubMed ID: 30733560
[TBL] [Abstract][Full Text] [Related]
8. Regression of cervical intraepithelial neoplasia by zerumbone in female Balb/c mice prenatally exposed to diethylstilboestrol: involvement of mitochondria-regulated apoptosis.
Abdelwahab SI; Abdul AB; Devi N; Taha MM; Al-zubairi AS; Mohan S; Mariod AA
Exp Toxicol Pathol; 2010 Sep; 62(5):461-9. PubMed ID: 19581075
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model.
Yuan L; Liu C; Chen Y; Zhang Z; Zhou L; Qu D
Int J Nanomedicine; 2013; 8():4339-50. PubMed ID: 24235831
[TBL] [Abstract][Full Text] [Related]
10. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
Liu D; Liu Z; Wang L; Zhang C; Zhang N
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
[TBL] [Abstract][Full Text] [Related]
11. Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model.
Nordin N; Yeap SK; Rahman HS; Zamberi NR; Mohamad NE; Abu N; Masarudin MJ; Abdullah R; Alitheen NB
Molecules; 2020 Jun; 25(11):. PubMed ID: 32526880
[TBL] [Abstract][Full Text] [Related]
12. Zerumbone induces apoptosis in T-acute lymphoblastic leukemia cells.
Abdelwahab SI; Abdul AB; Mohan S; Taha MM; Syam S; Ibrahim MY; Mariod AA
Leuk Res; 2011 Feb; 35(2):268-71. PubMed ID: 20708800
[TBL] [Abstract][Full Text] [Related]
13. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
Chen Y; Pan L; Jiang M; Li D; Jin L
Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel-loaded ultrasmall nanostructured lipid carriers for cancer therapy: in vitro and in vivo evaluation.
Li M; Pei J; Ma Z; Fu J; Chen F; Du S
Cancer Chemother Pharmacol; 2020 Apr; 85(4):731-739. PubMed ID: 32146495
[TBL] [Abstract][Full Text] [Related]
15. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol: Isolation, and Its Nanostructured Lipid Carriers, Inhibits Cell Proliferation, Induces Cell Apoptosis in Certain Human Cell Lines Carcinoma and Exerts Protective Effect Against Paraquat-Induced Hepatotoxicity.
Elgizawy HA; Ali AA; Hussein MA
J Med Food; 2021 Jan; 24(1):89-100. PubMed ID: 32580673
[TBL] [Abstract][Full Text] [Related]
17. Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide.
E M Eid E; S Alanazi A; Koosha S; A Alrasheedy A; Azam F; M Taban I; Khalilullah H; Sadiq Al-Qubaisi M; A Alshawsh M
Molecules; 2019 Jul; 24(14):. PubMed ID: 31337024
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapeutic effect of Zerumbone on melanoma cells through mitochondria-mediated pathways.
Wang SD; Wang ZH; Yan HQ; Ren MY; Gao SQ; Zhang GQ
Clin Exp Dermatol; 2016 Dec; 41(8):858-863. PubMed ID: 27759171
[TBL] [Abstract][Full Text] [Related]
19. Zerumbone causes Bax- and Bak-mediated apoptosis in human breast cancer cells and inhibits orthotopic xenograft growth in vivo.
Sehrawat A; Arlotti JA; Murakami A; Singh SV
Breast Cancer Res Treat; 2012 Nov; 136(2):429-41. PubMed ID: 23053663
[TBL] [Abstract][Full Text] [Related]
20. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.
Shao Z; Shao J; Tan B; Guan S; Liu Z; Zhao Z; He F; Zhao J
Int J Nanomedicine; 2015; 10():1223-33. PubMed ID: 25709444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
